Home | Medical-Newswire.Com:
|
(Medical-NewsWire.com, May 16, 2018 ) Genome editing is a type of genetic engineering technique that involves insertions, deletions, replacements or modifications of DNA in the genomes of living organisms.
Publisher's analysts forecast the global genome editing market to grow at a CAGR of 15.6% during the period 2018-2022.
FREE | Request Sample Copy is Available at http://www.reportsweb.com/inquiry&RW00011949678/sample
Covered in this report The report covers the present scenario and the growth prospects of the global genome editing market for 2018-2022. To calculate the market size, the report presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources.
The market is divided into the following segments based on geography: - Americas - APAC - EMEA
Publisher's report, Global Genome Editing Market 2018-2022, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
Key vendors - Genscript - Horizon Discovery Group - Lonza - Merck KGaA - Sangamo Therapeutics - Thermo Fisher Scientific
Buy now http://www.reportsweb.com/buy&RW00011949678/buy/3500 Market driver - Increase in applications of genome editing in therapeutics - For a full, detailed list, view our report
Market challenge - Lack of trained laboratory professionals - For a full, detailed list, view our report
Market trend - Global initiatives encouraging proteomics research - For a full, detailed list, view our report
Key questions answered in this report - What will the market size be in 2022 and what will the growth rate be? - What are the key market trends? - What is driving this market? - What are the challenges to market growth? - Who are the key vendors in this market space?
Table of Content
PART 01: EXECUTIVE SUMMARY PART 02: SCOPE OF THE REPORT PART 03: RESEARCH METHODOLOGY PART 04: MARKET LANDSCAPE - Market ecosystem - Market characteristics - Market segmentation analysis PART 05: MARKET SIZING - Market definition - Market sizing 2017 - Market size and forecast 2017-2022 PART 06: FIVE FORCES ANALYSIS - Bargaining power of buyers - Bargaining power of suppliers - Threat of new entrants - Threat of substitutes - Threat of rivalry - Market condition PART 07: MARKET SEGMENTATION BY END-USER - Segmentation by end-user - Comparison by end-user - Biotechnology and pharmaceutical companies - Academic institutes and research laboratories - CROs - Market opportunity by end-user PART 08: CUSTOMER LANDSCAPE PART 09: REGIONAL LANDSCAPE - Geographical segmentation - Regional comparison - Americas - EMEA - APAC - Market opportunity PART 10: DECISION FRAMEWORK PART 11: DRIVERS AND CHALLENGES - Market drivers - Market challenges PART 12: MARKET TRENDS - Technological advancement in genome editing tools - Global initiatives encouraging proteomics research - Advances in genome editing tools to improve development of vaccines PART 13: VENDOR LANDSCAPE - Overview - Landscape disruption PART 14: VENDOR ANALYSIS - Vendors covered - Vendor classification - Market positioning of vendors - Genscript - Horizon Discovery Group - Lonza - Merck KGaA - Sangamo Therapeutics - Thermo Fisher Scientific PART 15: APPENDIX
Complete Report is Available at http://www.reportsweb.com/global-genome-editing-market-2018-2022
ReportsWeb.com
Rajat Sahni
+1-646-491-9876
sales@reportsweb.com
Source: EmailWire.Com
Source: EmailWire.com
|
|
|
|